Antibody-Mediated Rejection Prevention Market Set to Surge to USD 528.31 Million by 2033 at a 16% of CAGR, Driven by Advances in Complement Inhibition Therapies
The global antibody-mediated rejection (AMR) prevention market is poised for significant growth, with an anticipated